Stephan Clasen
Overview
Explore the profile of Stephan Clasen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
784
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Clasen K, Gani C, Schuetz L, Clasen S, Ballin N, Bonzheim I, et al.
Radiat Oncol
. 2024 Nov;
19(1):153.
PMID: 39506775
Background: In locally advanced rectal cancer, the prediction of tumor response during and after neoadjuvant treatment remains challenging. In terms of organ preservation, adaptive radiotherapy, and intensified (total) neoadjuvant therapies,...
2.
Pereira P, Siemou P, Rempp H, Hoffmann R, Hoffmann R, Kettenbach J, et al.
Eur Radiol
. 2023 Dec;
34(7):4663-4671.
PMID: 38041717
Objectives: To compare the results of CT- vs MR-guided radiofrequency ablation (RFA) of liver metastases (LM) from colorectal cancer after 10 years of follow-up in an observational, retrospective, and multicentric...
3.
Gillissen A, Zimmermann T, Clasen S
Pneumologie
. 2022 May;
76(9):629-632.
PMID: 35504298
In this paper, we present a case of SARS-CoV2-Virus a non-vaccinated 54-year-old male admitted with COVID-19 pneumonia and respiratory insufficiency requiring high-flow oxygen supplementation. CT-scan of the lung revealed multifocal...
4.
Olthof S, Wessling D, Winkelmann M, Rempp H, Nikolaou K, Hoffmann R, et al.
Insights Imaging
. 2022 Mar;
13(1):48.
PMID: 35312842
Background: Radiofrequency ablation (RFA) is a minimal-invasive, local therapy in patients with circumscribed metastatic disease. Although widely used, long time survival analysis of treated liver metastases is still pending while...
5.
Clasen K, Gani C, Schroeder C, Riess O, Zips D, Schoffski O, et al.
Per Med
. 2022 Jan;
19(2):103-112.
PMID: 34984920
Willingness-to-pay (WTP) analyses can support allocation processes considering the patients preferences in personalized medicine. However, genetic testing especially might imply ethical concerns that have to be considered. A WTP questionnaire...
6.
Attenberger U, Clasen S, Ghadimi M, Grosse U, Antoch G, Schreyer A, et al.
Rofo
. 2020 Dec;
193(5):513-520.
PMID: 33327030
Due to its excellent intrinsic soft tissue contrast, magnetic resonance imaging allows excellent visualization and anatomical separation of therapy-relevant risk structures such as the mesorectal fascia, local lymph nodes, and...
7.
MR-Guided High-Power Microwave Ablation in Hepatic Malignancies: Initial Results in Clinical Routine
Winkelmann M, Gohla G, Kubler J, Weiss J, Clasen S, Nikolaou K, et al.
Cardiovasc Intervent Radiol
. 2020 Jul;
43(11):1631-1638.
PMID: 32699978
Purpose: Evaluation of technique effectiveness, patient safety and ablation parameters of MR-guided microwave ablation in hepatic malignancies using an MR-conditional high-power microwave ablation system. Materials And Methods: Institutional review board...
8.
Winkelmann M, Archid R, Gohla G, Hefferman G, Kubler J, Weiss J, et al.
Cancer Imaging
. 2020 May;
20(1):37.
PMID: 32460898
Background: Combination therapy using hepatic resection (HR) and intra-operative thermal ablation is a treatment approach for patients with technically unresectable liver malignancies. The aim of this study was to investigate...
9.
Weiss J, Winkelmann M, Gohla G, Kubler J, Clasen S, Nikolaou K, et al.
Int J Hyperthermia
. 2020 Apr;
37(1):349-355.
PMID: 32286087
To investigate technical success, technique efficacy, safety and outcome of MR-guided microwave ablation (MWA) in hepatic malignancies. In this prospective IRB-approved study, patients scheduled for percutaneous treatment of hepatic malignancies...
10.
Loffler M, Nussbaum B, Jager G, Jurmeister P, Budczies J, Pereira P, et al.
Front Immunol
. 2019 Dec;
10:2526.
PMID: 31803175
Radiofrequency ablation (RFA) is an established treatment option for malignancies located in the liver. RFA-induced irreversible coagulation necrosis leads to the release of danger signals and cellular content. Hence, RFA...